Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
Ongoing clinical trials of TYSABRI
Magnetic resonance imaging of blood brain/nerve barrier dysfunction and leukocyte infiltration: closely related or discordant?
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging.
An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial.
Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS.
Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Management of fatigue in persons with multiple sclerosis.
Inhibition of Endogenous Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis by Inducing Myeloid-Derived Suppressor Cells.
RORγt Expression and Lymphoid Neogenesis in the Brain of Patients with Secondary Progressive Multiple Sclerosis.
Effects of single dose mixed amphetamine salts - extended release on processing speed in multiple sclerosis: a double blind placebo controlled study.
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey.
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Myelin proteomics: the past, the unexpected and the future.
Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosis.
Validating archetypes for the Multiple Sclerosis Functional Composite.
Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.
Organic Causes of Erectile Dysfunction in Men Under 40.
Risk factors for falls in multiple sclerosis: an observational study.
Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence data.
Retraction notice: Language abilities of patients with primary progressive multiple sclerosis: A preliminary group and case investigation.
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
Impact on health-related quality of life in multiple sclerosis patients due to a managed care program in Colombia.
Pages
« first
‹ previous
…
391
392
393
394
395
396
397
398
399
…
next ›
last »